IL1B and metabolic dysfunction-associated steatotic liver disease: Additionally, QSPS-1D effectively reduced weight gain, hepatic lipid accumulation (TC and TG), and inflammatory responses (<i>tnf-α</i> and <i>il-1β</i>) in NAFLD zebrafish.